NSG 552 EXAM 1 PSYCHOPHARMACOLOGY -2 VERSIONS ACTUAL
PRACTICE QUESTIONS & ANSWERS - WILKES UNIVERSITY -
LATEST 2026/2027 - GRADED A+ INSTANT PDF DOWNLOAD
50 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Analyze the neurobiological mechanisms and receptor targets of major psychotropic drug classes
2 Apply pharmacokinetic and pharmacodynamic principles to individualize psychopharmacologic treatment
3 Evaluate clinical evidence and guidelines to select, monitor, and adjust psychotropic regimens safely
4 NSG 552 Exam 1 Psychopharmacology
5 2 versions Actual Practice Questions & Answers
6 Wilkes University
7 Latest 2026
8 2027
9 Graded A+ Instant Pdf Download
10 Foundations of Psychopharmacology
11 Applied Psychopharmacology
12 Advanced Psychopharmacology
13 Psychopharmacology Review
ABSTRACT
Page 1
,This study document brings together 50 carefully worded exam questions drawn from NSG 552
Exam 1 Psychopharmacology -2 versions Actual Practice Questions & Answers - Wilkes University
- Latest 2026/2027 - Graded A+ Instant Pdf Download, with the strongest emphasis placed on
Analyze the neurobiological mechanisms and receptor targets of major psychotropic drug classes,
Apply pharmacokinetic and pharmacodynamic principles to individualize psychopharmacologic
treatment, Evaluate clinical evidence and guidelines to select, monitor and and adjust psychotropic
regimens safely. Every item follows the wording style and level of reasoning you meet in the real
paper, and each one is paired with a clear rationale so the correct choice is never a guess. Work
through the set at your own pace, mark the questions that slow you down, then come back to them
until the reasoning feels automatic. Learners who revise this way walk into the exam room
recognising the pattern behind the questions instead of meeting them for the first time. Keep going
- steady, honest practice is what turns a difficult paper into a comfortable pass.
Q1 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
A patient with major depressive disorder and a known CYP2D6 poor metabolizer
status is started on a standard dose of venlafaxine. Which pharmacokinetic
principle best explains the anticipated need for dose reduction?
A. Venlafaxine is a prodrug requiring CYP2D6 activation, so poor metabolizers have reduced
efficacy.
B. Venlafaxine is primarily metabolized by CYP2D6 to its active metabolite, leading to higher
parent drug exposure in poor metabolizers. CORRECT
C. Venlafaxine is a CYP2D6 inhibitor, causing autoinhibition and nonlinear kinetics.
D. Venlafaxine is renally cleared unchanged, so CYP2D6 status is irrelevant.
RATIONALE: Venlafaxine is metabolized by CYP2D6 to O-desmethylvenlafaxine; poor
metabolizers have higher parent drug levels, increasing adverse effects. Options A, C, and D
misstate the metabolic pathway and clinical implication.
Page 2
, Q2 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
Which second-generation antipsychotic carries the highest risk of
agranulocytosis, necessitating mandatory ANC monitoring, and what is the
proposed mechanism?
A. Risperidone; dopamine D2 receptor blockade
B. Olanzapine; histamine H1 receptor antagonism
C. Clozapine; nitrenium ion formation causing neutrophil toxicity CORRECT
D. Quetiapine; muscarinic M1 receptor activation
RATIONALE: Clozapine is associated with the highest risk of agranulocytosis, linked to nitrenium
ion metabolites that are toxic to neutrophils. The other agents do not require mandatory ANC
monitoring for agranulocytosis.
Q3 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
A patient on lithium therapy presents with coarse tremor, ataxia, and confusion.
Serum lithium level is 2.0 mEq/L. Which intervention is the immediate priority?
A. Administer a benzodiazepine for agitation.
B. Initiate hemodialysis and supportive care. CORRECT
C. Increase sodium intake and recheck level in 6 hours.
D. Hold the next dose and administer activated charcoal.
RATIONALE: Lithium levels >2.0 mEq/L with neurotoxicity require hemodialysis to rapidly reduce
levels. Benzodiazepines, sodium loading, and charcoal are not definitive for severe toxicity.
Page 3
PRACTICE QUESTIONS & ANSWERS - WILKES UNIVERSITY -
LATEST 2026/2027 - GRADED A+ INSTANT PDF DOWNLOAD
50 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Analyze the neurobiological mechanisms and receptor targets of major psychotropic drug classes
2 Apply pharmacokinetic and pharmacodynamic principles to individualize psychopharmacologic treatment
3 Evaluate clinical evidence and guidelines to select, monitor, and adjust psychotropic regimens safely
4 NSG 552 Exam 1 Psychopharmacology
5 2 versions Actual Practice Questions & Answers
6 Wilkes University
7 Latest 2026
8 2027
9 Graded A+ Instant Pdf Download
10 Foundations of Psychopharmacology
11 Applied Psychopharmacology
12 Advanced Psychopharmacology
13 Psychopharmacology Review
ABSTRACT
Page 1
,This study document brings together 50 carefully worded exam questions drawn from NSG 552
Exam 1 Psychopharmacology -2 versions Actual Practice Questions & Answers - Wilkes University
- Latest 2026/2027 - Graded A+ Instant Pdf Download, with the strongest emphasis placed on
Analyze the neurobiological mechanisms and receptor targets of major psychotropic drug classes,
Apply pharmacokinetic and pharmacodynamic principles to individualize psychopharmacologic
treatment, Evaluate clinical evidence and guidelines to select, monitor and and adjust psychotropic
regimens safely. Every item follows the wording style and level of reasoning you meet in the real
paper, and each one is paired with a clear rationale so the correct choice is never a guess. Work
through the set at your own pace, mark the questions that slow you down, then come back to them
until the reasoning feels automatic. Learners who revise this way walk into the exam room
recognising the pattern behind the questions instead of meeting them for the first time. Keep going
- steady, honest practice is what turns a difficult paper into a comfortable pass.
Q1 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
A patient with major depressive disorder and a known CYP2D6 poor metabolizer
status is started on a standard dose of venlafaxine. Which pharmacokinetic
principle best explains the anticipated need for dose reduction?
A. Venlafaxine is a prodrug requiring CYP2D6 activation, so poor metabolizers have reduced
efficacy.
B. Venlafaxine is primarily metabolized by CYP2D6 to its active metabolite, leading to higher
parent drug exposure in poor metabolizers. CORRECT
C. Venlafaxine is a CYP2D6 inhibitor, causing autoinhibition and nonlinear kinetics.
D. Venlafaxine is renally cleared unchanged, so CYP2D6 status is irrelevant.
RATIONALE: Venlafaxine is metabolized by CYP2D6 to O-desmethylvenlafaxine; poor
metabolizers have higher parent drug levels, increasing adverse effects. Options A, C, and D
misstate the metabolic pathway and clinical implication.
Page 2
, Q2 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
Which second-generation antipsychotic carries the highest risk of
agranulocytosis, necessitating mandatory ANC monitoring, and what is the
proposed mechanism?
A. Risperidone; dopamine D2 receptor blockade
B. Olanzapine; histamine H1 receptor antagonism
C. Clozapine; nitrenium ion formation causing neutrophil toxicity CORRECT
D. Quetiapine; muscarinic M1 receptor activation
RATIONALE: Clozapine is associated with the highest risk of agranulocytosis, linked to nitrenium
ion metabolites that are toxic to neutrophils. The other agents do not require mandatory ANC
monitoring for agranulocytosis.
Q3 ANALYZE THE NEUROBIOLOGICAL MECHANISMS AND RECEPTOR TARGETS OF MAJOR
PSYCHOTROPIC DRUG CLASSES
A patient on lithium therapy presents with coarse tremor, ataxia, and confusion.
Serum lithium level is 2.0 mEq/L. Which intervention is the immediate priority?
A. Administer a benzodiazepine for agitation.
B. Initiate hemodialysis and supportive care. CORRECT
C. Increase sodium intake and recheck level in 6 hours.
D. Hold the next dose and administer activated charcoal.
RATIONALE: Lithium levels >2.0 mEq/L with neurotoxicity require hemodialysis to rapidly reduce
levels. Benzodiazepines, sodium loading, and charcoal are not definitive for severe toxicity.
Page 3
